Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1515, 2005-01, pp. : 9-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Lowering of LDL-cholesterol may increase risk of cancer
Reactions Weekly, Vol. 1, Iss. 1164, 2007-01 ,pp. :
Access to resources
Recommend
Ezetimibe/simvastatin: the elite LDL-cholesterol lowering entity?
Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. :
Aggressive lowering of LDL-cholesterol preferable?
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :
Lowering LDL Cholesterol: Where Is the End of the Journey?
Heart Drug, Vol. 5, Iss. 1, 2005-02 ,pp. :
Ezetimibe lowers LDL-cholesterol levels
Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. :